Evidence map›Paper›PMID 30643118›Full record

ArticleNature communications2019

Author Correction: Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features.

Jason J Pitt, Markus Riester, Yonglan Zheng, Toshio F Yoshimatsu, Ayodele Sanni, Olayiwola Oluwasola, Artur Veloso, Emma Labrot, Shengfeng Wang, Abayomi Odetunde and 44 more

Open access · goldAbstract readPublished Erratum
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

54 authors at 11 institutions in 8 countries.

Jason J PittInstitute for Genomics and Systems Biology, University of Chicago, Chicago, IL, 60637, USA.
Markus RiesterNovartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA.ORCID http://orcid.org/0000-0002-4759-8332
Yonglan ZhengCenter for Clinical Cancer Genetics & Global Health, Department of Medicine, University of Chicago, Chicago, IL, 60637, USA.ORCID http://orcid.org/0000-0001-6597-7072
Toshio F YoshimatsuCenter for Clinical Cancer Genetics & Global Health, Department of Medicine, University of Chicago, Chicago, IL, 60637, USA.ORCID http://orcid.org/0000-0003-2674-8159
Ayodele SanniDepartment of Pathology and Forensic Medicine, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria.
Olayiwola OluwasolaDepartment of Pathology, University of Ibadan, Ibadan, Oyo, Nigeria.
Artur VelosoNovartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA.
Emma LabrotNovartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA.
Shengfeng WangCenter for Clinical Cancer Genetics & Global Health, Department of Medicine, University of Chicago, Chicago, IL, 60637, USA.
Abayomi OdetundeInstitute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Oyo, Nigeria.
Adeyinka AdemolaDepartment of Surgery, University of Ibadan, Ibadan, Oyo, Nigeria.
Babajide OkedereInstitute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Oyo, Nigeria.
Scott MahanNovartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA.
Rebecca LearyNovartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA.
Maura MacomberNovartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA.
Mustapha AjaniDepartment of Pathology, University of Ibadan, Ibadan, Oyo, Nigeria.
Ryan S JohnsonNovartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA.
Dominic FitzgeraldInstitute for Genomics and Systems Biology, University of Chicago, Chicago, IL, 60637, USA.
A Jason GrundstadInstitute for Genomics and Systems Biology, University of Chicago, Chicago, IL, 60637, USA.
Jigyasa H TutejaInstitute for Genomics and Systems Biology, University of Chicago, Chicago, IL, 60637, USA.
Galina KhramtsovaCenter for Clinical Cancer Genetics & Global Health, Department of Medicine, University of Chicago, Chicago, IL, 60637, USA.
Jing ZhangCenter for Clinical Cancer Genetics & Global Health, Department of Medicine, University of Chicago, Chicago, IL, 60637, USA.
Elisabeth SveenCenter for Clinical Cancer Genetics & Global Health, Department of Medicine, University of Chicago, Chicago, IL, 60637, USA.
Bryce HwangNovartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA.
Wendy ClaytonCenter for Clinical Cancer Genetics & Global Health, Department of Medicine, University of Chicago, Chicago, IL, 60637, USA.
Chibuzor NkwodimmahDepartment of Surgery, University of Ibadan, Ibadan, Oyo, Nigeria.
Bisola FamootoDepartment of Surgery, University of Ibadan, Ibadan, Oyo, Nigeria.
Esther ObasiDepartment of Pathology and Forensic Medicine, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria.
Victor AderojuDepartment of Surgery, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria.
Mobolaji OludaraDepartment of Surgery, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria.
Folusho OmodeleDepartment of Surgery, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria.
Odunayo AkinyeleCenter for Clinical Cancer Genetics & Global Health, Department of Medicine, University of Chicago, Chicago, IL, 60637, USA.
Adewunmi AdeoyeDepartment of Pathology, University of Ibadan, Ibadan, Oyo, Nigeria.
Temidayo OgundiranDepartment of Surgery, University of Ibadan, Ibadan, Oyo, Nigeria.
Chinedum BabalolaInstitute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Oyo, Nigeria.
Kenzie MacIsaacNovartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA.
Abiodun PopoolaOncology Unit, Department of Radiology, Lagos State University, Ikeja, Lagos, Nigeria.
Michael P MorrisseyNovartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA.
Lin S ChenDepartment of Public Health Sciences, University of Chicago, Chicago, IL, 60637, USA.
Jiebiao WangDepartment of Public Health Sciences, University of Chicago, Chicago, IL, 60637, USA.
Christopher O OlopadeCenter for Clinical Cancer Genetics & Global Health, Department of Medicine, University of Chicago, Chicago, IL, 60637, USA.
Adeyinka G FalusiInstitute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Oyo, Nigeria.
Wendy WincklerNovartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA.
Kerstin HaaseThe Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.ORCID http://orcid.org/0000-0002-0944-5618
Peter Van LooThe Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.ORCID http://orcid.org/0000-0003-0292-1949
John ObafunwaDepartment of Pathology and Forensic Medicine, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria.
Dimitris PapoutsakisNovartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA.
Oladosu OjengbedeCentre for Population and Reproductive Health, College of Medicine, University of Ibadan, Ibadan, Oyo, Nigeria.
Barbara WeberNovartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA.
Nasiru IbrahimDepartment of Surgery, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria.
Kevin P WhiteInstitute for Genomics and Systems Biology, University of Chicago, Chicago, IL, 60637, USA. kpwhite@uchicago.edu.
Dezheng HuoCenter for Clinical Cancer Genetics & Global Health, Department of Medicine, University of Chicago, Chicago, IL, 60637, USA. dhuo@health.bsd.uchicago.edu.
Olufunmilayo I OlopadeInstitute for Genomics and Systems Biology, University of Chicago, Chicago, IL, 60637, USA. folopade@medicine.bsd.uchicago.edu.ORCID http://orcid.org/0000-0002-9936-1599
Jordi BarretinaNovartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA. jordi.barretina@gmail.com.ORCID http://orcid.org/0000-0002-3478-4080
Novartis (United States) · USUniversity of Chicago · USUniversity of Ibadan · NGLagos State University Teaching Hospital · NGChicago Department of Public Health · USThe Francis Crick Institute · GBLagos State University · NGNational University of Singapore · SGNovartis (Switzerland) · CHPeking University · CNUniversity of Illinois Chicago · US

Funding

Using Genomics to Reduce Breast Cancer Disparities in the African DiasporaU01CA161032 · NCI · UNIVERSITY OF CHICAGO · PI HUO, DEZHENG, OLOPADE, OLUFUNMILAYO F. · 2012 to 2015
$3.6M
U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) U01-CA161032
6 · The paper itself

Abstract

The original version of this Article contained an error in the author affiliations. The affiliation of Kevin P. White with Tempus Labs, Inc. Chicago, IL, USA was inadvertently omitted. This has now been corrected in both the PDF and HTML versions of the Article.

Identifiers

PMID30643118
PMCPMC6331546
OpenAlexW2908994497

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.